Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Biothera - Biothera Launches Clinical Trial in KRAS-Mutated Colorectal Cancer Patients
Pharmacokinetics - Neurocrine Biosciences Presents Elagolix Data
Tuberculosis - Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development
Acute Myelogenous Leukemia - Study data from J.E. Karp and colleagues update understanding of acute myelogenous leukemia
Alzheimer Disease - Recent findings in Alzheimer disease described by R.H. Pietrzak and colleagues
Bladder Cancer - Reports from University of Oviedo describe recent advances in bladder cancer
Cancer Vaccines - Reports summarize cancer vaccines study results from University of Manchester
Chronic Myelogenous Leukemia - New findings in chronic myelogenous leukemia described by T. Tyler and co-researchers
Headache and Migraine - Research results from A. Wade and colleagues update understanding of headache and migraine
Hematologic Disease - New hematologic disease research from A. Dodero et al outlined
Life Sciences - Research on life sciences discussed by scientists at Technion
Lung Cancer - Findings from P. Garrido and co-researchers advance knowledge in lung cancer
Malt Lymphoma - Data on malt lymphoma described by researchers at Medical University of Vienna
Monoclonal Antibodies - New monoclonal antibodies study findings reported from Johns Hopkins University
Pharmaceuticals - New pharmaceuticals study findings reported from S. Meini and co-authors
Prostate Cancer - Research conducted at University of Washington has updated our knowledge about prostate cancer
Prostatic Hyperplasia - New research on prostatic hyperplasia from University of California, Medical Department summarized
Suicide - Studies from F. Ciceri and co-authors have provided new information about suicide
Transplantation - Research on transplantation detailed by S.W. Kim and co-authors
Tuberculosis - Research on tuberculosis described by scientists at Tibotec
Type 2 Diabetes - Reports from Bristol-Myers Squibb Company advance knowledge in type 2 diabetes
Urothelial Cancer - Reports summarize urothelial cancer study results from University of California
Cancer Gene Therapy Vaccines - Data on cancer gene therapy vaccines described by researchers at University of Sao Paulo, Heart Institute
Cancer Prevention - Research from Memorial Sloan Kettering Cancer Center, Department of Medicine in the area of cancer prevention published
Clinical Trial Research - Research from University of Verona in the area of clinical trial research published
Immunotherapy - Studies in the area of immunotherapy reported from University Hospital
Lymphoma Immunotherapy - Research from Nagoya City University broadens understanding of lymphoma immunotherapy
Abdominal Aortic Aneurysm - Arizona Heart Institute Enrolls First Patient in Anaconda(TM) Investigational Study for the Treatment of Abdominal Aortic Aneurysm
Abraxis Bioscience, Inc. - Abraxis Bioscience Launches ABRAXANE® in China for Women with Metastatic Breast Cancer
Advaxis, Incorporated - Advaxis’ Clinical Trial Survival Data Significantly Exceeds the National Cancer Institute's Median Survival Statistic
Altus Pharmaceuticals Inc. - Altus Pharmaceuticals Reports Dosing First Patient in a Phase 2 Trial of ALTU-238 for Pediatric Growth Hormone Deficiency
Amarin Corporation plc - Amarin Announces Results from Exploratory Phase 2a Study of EN101 in Myasthenia Gravis
Anavex Life Sciences Corp. - ANAVEX appoints Dr. Herve de Kergrohen as CEO to lead company through clinical trials and future growth
Antigenics Inc. - Antigenics’ QS-21 Adjuvant Enters Pivotal Phase 3 Clinical Trial of GlaxoSmithKline’s Malaria Vaccine
Aradigm Corporation - Aradigm Presents Phase 1 and Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Healthy Volunteers and Cystic Fibrosis Patients at the 32nd European Cystic Fibrosis Conference
Ardea Biosciences, Inc. - Ardea Biosciences Announces Positive Interim Phase 2a Results for Lead Gout Drug, RDEA594
Bayhill Therapeutics Inc. - Bayhill Therapeutics Enters Exclusive, Worldwide Collaboration with Genentech for BHT-3021 in Type 1 Diabetes
Bio-Light Israeli Life Science Investments Ltd. - Obecure Achieves Successful Results in Its Proof of Concept Clinical Study Evaluating the Ability of HistaleanTM to Mitigate Weight Gain Associated With Olanzapine
Brain Cancer - Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer
Cancer Vaccines - Cancer Treatment Centers of America(R) Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells
Cancer Vaccines - Oncothyreon appoints Scott Peterson as Vice President of Research and Development
Clinical Trial Research - ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps(TM)
Clinical Trial Research - Transdel Pharmaceuticals Provides Update on Timing of Results for Phase 3 Study
Depomed, Inc. - Depomed to Present at Jefferies 3rd Annual Healthcare Conference
Diabetes - Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections
Emphysema - Broncus Technologies' Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group
GTx, Inc. - GTx Presents Phase II Ostarine MK-2866 Cancer Cachexia Clinical Trial Results at Endocrine Society Annual Meeting
HEALTHPOINT, Ltd. - HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study
Idera Pharmaceuticals, Inc. - Idera Pharmaceuticals Provides Update on Drug Candidate Pipeline Targeted to Toll-like Receptors
Javelin Pharmaceuticals, Inc. - New Study Shows Javelin Pharmaceutical’s DylojectTM Well-Tolerated in High-Risk Patients with Impaired Renal and Hepatic Function
Neurofibromatosis - PTC Therapeutics Receives $2.6 Million in Government Grants
Pfizer Inc - Pfizer’s Oral JAK-3 Inhibitor Demonstrates Statistically Significant Response for Patients with Rheumatoid Arthritis, New Phase 2 Studies Show
Pharmaceuticals - DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
Pharmaceuticals - FluoroPharma to Present Phase I Study Results of Novel Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI) Tracer
ProFibrix B.V. - ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps
QuantRx Biomedical Corporation - QuantRx Announces FluoroPharma to Present Phase I Study Results of Novel Positron Emission Tomography PET Myocardial Perfusion Imaging MPI Tracer
Regeneron Pharmaceuticals, Inc. - Sanofi-aventis and Regeneron Announce Results from Phase 2 Study with Aflibercept VEGF Trap in Advanced Ovarian Cancer Patients with Recurrent Symptomatic Malignant Ascites
Rexahn Pharmaceuticals, Inc. - New Animal Study of Rexahn’s Serdaxin™ Shows Drug’s Promise to Treat Anxiety and Depression with Minimal Side Effects
Type 1 Diabetes - MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
